The potential downgrade by MSCI, an influential index provider, adds to a deepening crisis of investor confidence in the economic policies of Indonesian President Prabowo Subianto.
The attorneys general of New York and six other states joined the Federal Trade Commission in accusing the disgraced former pharmaceutical executive of repeatedly violating the ban.